Insights into novel diagnostic assay development, antimicrobial resistance, and pathogenicity in Proteus mirabilis

Zhiqiu Yin1, Xiaman Chen1, Juncong Xiao2,3,4

  • 1Department of Clinical Laboratory, Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.

Insights

This study identifies specific genes in Proteus mirabilis, a multidrug-resistant (MDR) pathogen causing urinary tract infections (UTIs). Novel PCR assays were developed for accurate detection and to understand its increasing antimicrobial resistance (AMR).

Area of Science:

  • Genomics and Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Proteus mirabilis is a significant cause of urinary tract infections (UTIs).
  • Increasing multidrug resistance (MDR) in P. mirabilis complicates clinical treatment and infection control.
  • Accurate identification and genomic understanding are crucial for managing this pathogen.

Purpose of the Study:

  • To identify species-specific genes in P. mirabilis through pan-genome analysis.
  • To develop novel detection methods based on identified genetic markers.
  • To elucidate the antimicrobial resistance (AMR) and virulence profiles of P. mirabilis.

Main Methods:

  • Pan-genome analysis of the Proteus genus to identify species-specific gene repertoires.
  • Development of conventional PCR and TaqMan probe-based real-time PCR assays using PMI3020 and PMI3598 as targets.
  • Comparative genomic analysis of AMR and virulence genes across Proteus species.

Main Results:

  • Two species-specific core genes (PMI3020, PMI3598) were identified in P. mirabilis.
  • Developed PCR assays demonstrated high specificity for P. mirabilis detection.
  • Real-time PCR achieved a sensitivity of 3.43 × 10² CFU/mL.
  • P. mirabilis possesses a greater abundance of AMR and virulence genes compared to other Proteus species, correlating with higher AMR prevalence and MDR risks (carbapenems, cephalosporins).

Conclusions:

  • Pan-genome analysis is effective for identifying specific genetic markers for pathogen detection.
  • Novel PCR assays enable accurate and sensitive detection of P. mirabilis.
  • Genomic insights into AMR and virulence provide a foundation for public health risk assessment of P. mirabilis.